Share data
16/05/2024
China Traditional Chinese Medicine Holdings Co. Limited is the core modern TCM platform by China National Pharmaceutical Group Co., Ltd. The Company (stock code: 00570.HK) is listed on the Main Board of the Hong Kong Stock Exchange. Headquartered in Foshan, Guangdong. With “implement the national development strategies of TCM to lead the high-quality development of TCM industry” as the mission, the Company establishes the largest TCM manufacturing industry cluster in China, and its business integrates six segments: medicinal herbs plantation and trading, TCM decoction pieces, concentrated TCM granules, TCM finished drugs, TCM healthcare product and TCM clinics.
Share Graph
| Currency | HKD |
| Previous Close | 4.28 |
| Change (%) | -0.47 |
| Volume | 26,699,316 |
| Number of Shares | 5,035,801,852 |
| Market Cap (mln) | 21,553 |
| Financial Highlights, RMB'000 | 2021 | 2022 | 2023 |
| Results | |||
| Revenue | 19,052,802 | 14,304,242 | 18,121,861 |
| Gross profit | 11,829,163 | 7,198,452 | 9,274,492 |
| Profit from operations | 2,753,058 | 1,064,283 | 1,427,277 |
| Profit before taxation | 2,520,280 | 840,109 | 1,224,533 |
| Profit attributable to the shareholders of the Company | 1,932,858 | 764,486 | 1,285,200 |
| Profitability | |||
| Gross profit margin (%) | 62.09 | 50.32 | 51.18 |
| Operating profit margin (%) | 14.45 | 7.44 | 7.88 |
| Net profit margin (%) | 11.14 | 5.04 | 7.70 |
| Earnings per share | |||
| Basic & Diluted (cents) | 38.38 | 15.18 | 25.52 |
| Financial Position | |||
| Total assets | 36,389,268 | 35,636,977 | 37,068,348 |
| Total equity attributable to equity shareholders of the Company | 19,718,669 | 20,168,127 | 21,160,135 |
| Total liabilities | 13,728,339 | 12,688,862 | 13,131,730 |
| Cash and cash equivalents | 2,894,757 | 3,065,054 | 3,017,318 |
| Debt asset ratio (%) | 37.73 | 35.61 | 35.43 |
Supplied by ©
